杨修亮

杨修亮, listed as senior executive, appears in our data through filings on 金城医药 shares, published by SSE / SZSE (CSRC). The record holds 2 filings, for trades running from 12 January 2022 to 13 January 2022.

Sales make up the whole of the open-market record (2 sales, €24k).

The newest entry dates from 13 January 2022: an open-market sale of €9,607, in 金城医药. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.